Together we can save lives.
Since its inception in 1998, the Harry Perkins Institute of Medical Research has made significant discoveries into the diseases that plague our families, in particular heart disease, diabetes and cancer. With over 200 researchers, scientists and doctors housed in two state-of-the-art research facilities, the Perkins creates a culture of innovation and collaboration. Teams dedicated to finding answers to defeat cancers are funded from the MACA Cancer 200 each year.
1 in 2 Australians will be diagnosed with cancer by the age of 85
Over 145,000 new cases of cancer in Australia every year
Honour Roll Fellow
Dr Louise Winteringham
Liver cancer is one of the fastest growing cancers on the planet. Along with her role as head of the translational cancer research department – that is focused on testing and advancing the latest cancer discoveries in the lab – Louise manages a consortium of over 50 liver cancer researchers.
Cancer Drug Delivery Project
Associate Professor Juliana Hamzah
Juliana researches new modes of cancer drug delivery to treat the cancer cells more quickly. She is developing an agent that breaks down tough scar tissue that forms around liver, pancreatic and some breast cancers to allow patients’ immune cells to access the tumour and kill the cancer cells more effectively.
Single-Cell Sequencing Project
Deputy Director Prof. Alistair Forrest
Alistair researches the genomics of cancer tumours using a single-cell sequencer that can process the hardest to treat cancer tumours – including liver, brain, lung, melanoma and pancreatic. In less than a day this process reveals every individual part of the tumour in microscopic details.
Breast and Brain Cancer
Associate Prof. Pilar Blancafort
Pilar holds half of the patent for the discovery that honeybee venom can kill breast cancer cells in the lab and is continuing to refine this research. She is also working on a brain cancer project focused on turning off genes designed to repair cancer cells.
Melanoma Research team
Professor Jonas Nilsson
Jonas and his relocated Swedish team focus on altering immune cells outside a patient’s body so the enhanced cells can be reintroduced in large numbers to help fight the cancer cells.